Mitochondrial dysfunction in AIDS and its treatment

Mitochondrion

Volumn 4, Issue 5-6 SPEC. ISS., 2004, Pages 763-777

  Gerschenson, Mariana ^a   Brinkman, Kees ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Antiretroviral; Apoptosis; DNA polymerase ; HIV; Mitochondria; Uncoupling protein

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; CARBOVIR; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; DIDANOSINE; DNA DIRECTED DNA POLYMERASE GAMMA; EFAVIRENZ; HYDROXYUREA; IBUPROFEN; LAMIVUDINE; MITOCHONDRIAL DNA; NELFINAVIR; PROTEIN BCL 2; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; THYMIDINE KINASE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; UNINDEXED DRUG; VALPROIC ACID; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CARDIOMYOPATHY; DRUG MECHANISM; FATTY LIVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LIPODYSTROPHY; LONG TERM CARE; MITOCHONDRIAL TOXICITY; MITOCHONDRION; MYELOPOIESIS; MYOPATHY; NEUROPATHY; OXIDATIVE STRESS; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 9244249624     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2004.07.025     Document Type: Article

References (158)

1. A. Alimenti D.R. Burdge G.S. Ogilvie D.M. Money J.C. Forbes Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy Pediatr. Infect. Dis. J. 22 2003 782-789
2. U. Andersson R.C. Scarpulla Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells Mol. Cell. Biol. 21 2001 3738-3749
3. A. Arenas-Pinto A.D. Grant S. Edwards I.V. Weller Lactic acidosis in HIV infected patients: A systematic review of published cases Sex. Transm. Infect. 79 2003 340-343
4. C. Arici A. Tebaldi G.P. Quinzan F. Maggiolo D. Ripamonti F. Suter Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART Int. J. STD AIDS 12 2001 407-409
5. D. Arnoult F. Petit J.D. Lelievre J. Estaquier Mitochondria in HIV-1-induced apoptosis Biochem. Biophys. Res. Commun. 304 2003 561-574
6. K.M. Ayers Preclinical toxicology of zidovudine. An overview Am. J. Med. 85 1988 186-188
7. A.D. Badley T. Roumier J.J. Lum G. Kroemer Mitochondrion-mediated apoptosis in HIV-1 infection Trends Pharmacol. Sci. 24 2003 298-305
8. D. Baram J. Cooke Lactic acidosis and AIDS Ann. Intern. Med. 119 1993 345
9. M. Barile D. Valenti G.A. Hobbes Mechanism of toxicity of 3′-azido-3′-deoxythymidine. Its interaction with adenylate kinase Biochem. Pharmacol. 53 1997 913-920
10. M. Barile D. Valenti S. Passarella E. Quagliariello 3′-Azido-3′-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator Biochem. Pharmacol. 53 1997 913-920
11. B. Barret M. Tardieu P. Rustin C. Lacroix B. Chabrol I. Desguerre C. Dollfus M.J. Mayaux S. Blanche Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort Aids 17 2003 1769-1785
12. M.W. Becher M.L. Wills W.W. Noll O. Hurko D.L. Price Kearns-Sayre syndrome with features of Pearson's marrow-pancreas syndrome and a novel 2905-base pair mitochondrial DNA deletion Hum. Pathol. 30 1999 577-581
13. A. Bialkowska K. Bialkowski M. Gerschenson B.A. Diwan A.B. Jones O.A. Olivero M.C. Poirier L.M. Anderson K.S. Kasprzak M.A. Sipowicz Oxidative DNA damage in fetal tissues after transplacental exposure to 3′-azido-3′-deoxythymidine (AZT) Carcinogenesis 21 2000 1059-1062
14. G. Biesecker S. Karimi J. Desjardins D. Meyer B. Abbott R. Bendele F. Richardson Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks Antivir. Res. 58 2003 217-225
15. G. Birkus M. Hajek P. Kramata I. Votruba A. Holy B. Otova Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon* Antimicrob. Agents Chemother. 46 2002 1610-1613
16. F. Bissuel F. Bruneel F. Habersetzer D. Chassard L. Cotte M. Chevallier J. Bernuau J.C. Lucet C. Trepo Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy J. Intern. Med. 235 1994 367-371
17. S. Blanche M. Tardieu P. Rustin A. Slama B. Barret G. Firtion N. Ciraru-Vigneron C. Lacroix C. Rouzioux L. Mandelbrot I. Desguerre A. Rotig M.J. Mayaux J.F. Delfraissy Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084-1089
18. M. Boffito G. Marietti S. Audagnotto R. Raiter G. Di Perri Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors Clin. Infect. Dis. 34 2002 558-559
19. V.A. Bohr T. Stevnsner N.C. de Souza-Pinto Mitochondrial DNA repair of oxidative damage in mammalian cells Gene 286 2002 127-134
20. K. Boubaker M. Flepp P. Sudre H. Furrer A. Haensel B. Hirschel K. Boggian J.P. Chave E. Bernasconi M. Egger M. Opravil M. Rickenbach P. Francioli A. Telenti Hyperlactatemia and antiretroviral therapy: The Swiss HIV Cohort Study Clin. Infect. Dis. 33 2001 1931-1937
21. Boxwell, D.E., Toerner, J., 2001. Fatal hepatotoxicity associated with combination hydroxyurea and nucleoside reverse transcriptase inhibitors (NRTIs): Cases from the FDA Adverse Event Reporting System (AERS). 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, Abstract 617.
22. C. Brenner G. Kroemer The mitochondriotoxic domain of Vpr determines HIV-1 virulence J. Clin. Invest. 111 2003 1455-1457
23. B.J. Brew S. Tisch M. Law Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy Aids 17 2003 1094-1096
24. K. Brinkman Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors Clin. Infect. Dis. 31 2000 167-169
25. K. Brinkman Management of hyperlactatemia: No need for routine lactate measurements Aids 15 2001 795-797
26. K. Brinkman H.J. ter Hofstede Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors; lactic acidosis, risk factors, and therapeutic options AIDS Rev. 1 1999
27. K. Brinkman S. Vrouenraets R. Kauffmann H. Weigel J. Frissen Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis Aids 14 2000 2801-2802
28. Brinkman, K., Troost, N., Schrijnders, L., Regez, R.M., Treskes, M., 2002. Usefulness of routine lactate measurement to prevent lactic acidosis: Evaluation of a protocol. 9th Conference on Retrovirus and Opportunistic Infections, Seattle, USA, Abstract 709.
29. F.G. Brivet I. Nion B. Megarbane A. Slama M. Brivet P. Rustin A. Munnich Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: A respiratory chain dysfunction? J. Hepatol. 32 2000 364-365
30. M. Bulterys S. Nesheim E.J. Abrams P. Palumbo J. Farley M. Lampe M.G. Fowler Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study Ann. N. Y. Acad. Sci. 918 2000 212-221
31. A.A. Butt Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy AIDS Read. 13 2003 344-348
32. A. Carr Lactic acidemia in infection with human immunodeficiency virus Clin. Infect. Dis. 36 2003 S96-S100
33. A. Carr C. Workman D.E. Smith J. Hoy J. Hudson N. Doong A. Martin J. Amin J. Freund M. Law D.A. Cooper Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: A randomized trial J. Am. Med. Assoc. 288 2002 207-215
34. J. Casademont A. Barrientos J.M. Grau E. Pedrol X. Estivill A. Urbano-Marquez V. Nunes The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction Brain 119 Pt 4 1996 1357-1364
35. P. Chariot I. Drogou I. de Lacroix-Szmania M.C. Eliezer-Vanerot B. Chazaud A. Lombes A. Schaeffer E.S. Zafrani Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion J. Hepatol. 30 1999 156-160
36. D. Chen M. Wang S. Zhou Q. Zhou HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim Eur. Mol. Biol. Org. J. 21 2002 6801-6810
37. C.L. Cherry J.C. McArthur J.F. Hoy S.L. Wesselingh Nucleoside analogues and neuropathy in the era of HAART J. Clin. Virol. 26 2003 195-207
38. N. Christeff J.C. Melchior P. de Truchis C. Perronne M.L. Gougeon Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome Eur. J. Clin. Invest. 32 2002 43-50
39. T. Cihlar G. Birkus D.E. Greenwalt M.J. Hitchcock Tenofovir exhibits low cytotoxicity in various human cell types: Comparison with other nucleoside reverse transcriptase inhibitors Antivir. Res. 54 2002 37-45
40. Y.E. Claessens J.D. Chiche J.P. Mira A. Cariou Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors Crit. Care 7 2003 226-232
41. H. Cohen I. Williams F. Matthey R.F. Miller S.J. Machin I.V. Weller Reversible zidovudine-induced pure red-cell aplasia Aids 3 1989 177-178
42. A.C. Collier R.J. Helliwell J.A. Keelan J.W. Paxton M.D. Mitchell M.D. Tingle 3′-Azido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta Toxicol. Appl. Pharmacol. 192 2003 164-173
43. L. Conti G. Rainaldi P. Matarrese B. Varano R. Rivabene S. Columba A. Sato F. Belardelli W. Malorni S. Gessani The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS J. Exp. Med. 187 1998 403-413
44. T. Dagan C. Sable J. Bray M. Gerschenson Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: What is the evidence Mitochondrion 1 2002 397-412
45. M.C. Dalakas I. Illa G.H. Pezeshkpour J.P. Laukaitis B. Cohen J.L. Griffin Mitochondrial myopathy caused by long-term zidovudine therapy N. Engl. J. Med. 322 1990 1098-1105
46. M.C. Dalakas C. Semino-Mora M. Leon-Monzon Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC) Lab. Invest. 81 2001 1537-1544
47. Davies, E., Morlese, J., Asboe, D., Mandalia, S., Datta, D., Moyle, G.J., Gazzard, B.G., 2001. Reduction in hyperlactataemia with dichloroacetate in HIV-1 infected patients. 8th ECCAT, Athens, Greece, Abstract P147.
48. J.G. de la Asuncion M.L. del Olmo J. Sastre A. Millan A. Pellin F.V. Pallardo J. Vina AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins J. Clin. Invest. 102 1998 4-9
49. S. DiMauro E.A. Schon Mitochondrial respiratory-chain diseases N. Engl. J. Med. 348 2003 2656-2668
50. P. Domingo X. Matias-Guiu R.M. Pujol E. Francia E. Lagarda M.A. Sambeat G. Vazquez Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy Aids 13 1999 2261-2267
51. K. Dominguez J. Bertolli M. Fowler V. Peters I. Ortiz S. Melville T. Rakusan T. Frederick H. Hsu P. D'Almada Y. Maldonado C. Wilfert Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children < or =5 years of age, Pediatric Spectrum of HIV Disease project (PSD), USA Ann. N. Y. Acad. Sci. 918 2000 236-246
52. C. Erlanson-Albertsson Uncoupling proteins-a new family of proteins with unknown function Nutr. Neurosci. 5 2002 1-11
53. J. Estaquier J.D. Lelievre F. Petit T. Brunner L. Moutouh-De Parseval D.D. Richman J.C. Ameisen J. Corbeil Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death J. Virol. 76 2002 5966-5973
54. E.L. Ewings M. Gerschenson M.C. St Claire K. Nagashima B. Skopets S.W. Harbaugh J.W. Harbaugh M.C. Poirier Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria J. Acquir. Immune Defic. Syndr. 24 2000 100-105
55. W.A. Eyer-Silva J. Arabe J.F. Pinto C.A. Morais-De-Sa Macrocytosis in patients on stavudine Scand. J. Infect. Dis. 33 2001 239-240
56. V. Falco D. Rodriguez E. Ribera E. Martinez J.M. Miro P. Domingo R. Diazaraque J.R. Arribas J.J. Gonzalez-Garcia F. Montero L. Sanchez A. Pahissa Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: Report of 12 cases and review of the literature Clin. Infect. Dis. 34 2002 838-846
57. K.F. Ferri E. Jacotot J. Blanco J.A. Este N. Zamzami S.A. Susin Z. Xie G. Brothers J.C. Reed J.M. Penninger G. Kroemer Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: Role of mitochondria and caspases J. Exp. Med. 192 2000 1081-1092
58. Fleischer, R., Boxwell, D.E., Sherman, K.E., 2003. Evidence suggesting mitochondrial toxicity in HIV/HCV co-infected patients receiving ribavirin and didanosine. 10th Conference on Retroviruses and Opportunistic Infections, Boston, Abstract 763.
59. I.S. Fortgang P.C. Belitsos R.E. Chaisson R.D. Moore Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy Am. J. Gastroenterol. 90 1995 1433-1436
60. B. Fouty F. Frerman R. Reves Riboflavin to treat nucleoside analogue-induced lactic acidosis Lancet 352 1998 291-292
61. F. Frippiat G. Derue F. Heller P. Honore M. Moreau B. Vandercam Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy J. Antimicrob. Chemother. 45 2000 411-412
62. B. Fromenty A. Berson D. Pessayre Microvesicular steatosis and steatohepatitis: Role of mitochondrial dysfunction and lipid peroxidation J. Hepatol. 26 Suppl 1 1997 13-22
63. T. Garcia-Benayas F. Blanco J.J. de la Cruz V. Soriano J. Gonzalez-Lahoz Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy Aids 17 2003 921-924
64. D. Geene P. Sudre D. Anwar C. Goehring A. Saaidia B. Hirschel Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study J. Infect. 40 2000 160-163
65. Y. Gerard L. Maulin Y. Yazdanpanah X. De La Tribonniere C. Amiel C.A. Maurage S. Robin B. Sablonniere C. Dhennain Y. Mouton Symptomatic hyperlactataemia: An emerging complication of antiretroviral therapy Aids 14 2000 2723-2730
66. M. Gerschenson Mitochondria and lipodystrophy: Where are we now? Antivir. Ther. 8 2003 261-263
67. M. Gerschenson M.C. Poirier Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure Ann. N. Y. Acad. Sci. 918 2000 269-281
68. M. Gerschenson S.W. Erhart C.Y. Paik M.C. St Claire K. Nagashima B. Skopets S.W. Harbaugh J.W. Harbaugh W. Quan M.C. Poirier Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine AIDS Res. Hum. Retroviruses 16 2000 635-644
69. M. Gerschenson V.T. Nguyen M.C. St Claire S.W. Harbaugh J.W. Harbaugh L.A. Proia M.C. Poirier Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeys J. Hum. Virol. 4 2001 335-342
70. E. Gertner J.R. Thurn D.N. Williams M. Simpson H.H. Balfour Jr. F. Rhame K. Henry Zidovudine-associated myopathy Am. J. Med. 86 1989 814-818
71. C. Giaquinto A. De Romeo V. Giacomet O. Rampon E. Ruga A. Burlina A. De Rossi M. Sturkenboom R. D'Elia Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission Aids 15 2001 1074-1075
72. T. Hagen A. Vidal-Puig Mitochondrial uncoupling proteins in human physiology and disease Minerva Med. 93 2002 41-57
73. M.T. Haupt J.A. Kruse R.W. Carlson Lactic acidosis and AIDS Ann. Intern. Med. 119 1993 343-344
74. D.V. Havlir P.B. Gilbert K. Bennett A.C. Collier M.S. Hirsch P. Tebas E.M. Adams L.J. Wheat D. Goodwin S. Schnittman M.K. Holohan D.D. Richman Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression Aids 15 2001 1379-1388
75. E. Jacotot L. Ravagnan M. Loeffler K.F. Ferri H.L. Vieira N. Zamzami P. Costantini S. Druillennec J. Hoebeke J.P. Briand T. Irinopoulou E. Daugas S.A. Susin D. Cointe Z.H. Xie J.C. Reed B.P. Roques G. Kroemer The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore J. Exp. Med. 191 2000 33-46
76. E. Jacotot K.F. Ferri C. El Hamel C. Brenner S. Druillennec J. Hoebeke P. Rustin D. Metivier C. Lenoir M. Geuskens H.L. Vieira M. Loeffler A.S. Belzacq J.P. Briand N. Zamzami L. Edelman Z.H. Xie J.C. Reed B.P. Roques G. Kroemer Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2 J. Exp. Med. 193 2001 509-519
77. P. Jezek Possible physiological roles of mitochondrial uncoupling proteins-UCPn Int. J. Biochem. Cell. Biol. 34 2002 1190-1206
78. M. John C.B. Moore I.R. James D. Nolan R.P. Upton E.J. McKinnon S.A. Mallal Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy Aids 15 2001 717-723
79. M. John D. Nolan S. Mallal Antiretroviral therapy and the lipodystrophy syndrome Antivir. Ther. 6 2001 9-20
80. M. John E.J. McKinnon I.R. James D.A. Nolan S.E. Herrmann C.B. Moore A.J. White S.A. Mallal Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients J. Acquir. Immune Defic. Syndr. 33 2003 29-33
81. J.A. Johnson J.B. Albu E.S. Engelson S.K. Fried Y. Inada G. Ionescu D.P. Kotler Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy Am. J. Physiol. Endocrinol. Metab. 2003
82. S. Johri S. Alkhuja G. Siviglia A. Soni Steatosis-lactic acidosis syndrome associated with stavudine and lamivudine therapy Aids 14 2000 1286-1287
83. T.N. Kakuda Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity Clin. Ther. 22 2000 685-708
84. T.N. Kakuda K. Brinkman Mitochondrial toxic effects and ribavirin Lancet 357 2001 1802-1803
85. K. Kannisto J. Sutinen E. Korsheninnikova R.M. Fisher E. Ehrenborg K. Gertow A. Virkamaki T. Nyman H. Vidal A. Hamsten H. Yki-Jarvinen Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy Aids 17 2003 1753-1762
86. S. Khouri H. Cushing Lactic acidosis secondary to nucleoside analogue antiretroviral therapy AIDS Read. 10 2000 602-606
87. P.S. Kishnani J.L. Van Hove J.S. Shoffner A. Kaufman E.H. Bossen S.G. Kahler Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu(UUR) gene Eur. J. Pediatr. 155 1996 898-903
88. A. Lafeuillade G. Hittinger S. Chadapaud Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection Lancet 357 2001 280-281
89. E. Ledru N. Christeff O. Patey P. de Truchis J.C. Melchior M.L. Gougeon Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome Blood 95 2000 3191-3198
90. W. Lewis B. Gonzalez A. Chomyn T. Papoian Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria J. Clin. Invest. 89 1992 1354-1360
91. W. Lewis B.J. Day W.C. Copeland Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective Nat. Rev. Drug Discov. 2 2003 812-822
92. S.E. Lim W.C. Copeland Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma J. Biol. Chem. 276 2001 23616-23623
93. S.E. Lim M.V. Ponamarev M.J. Longley W.C. Copeland Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs J. Mol. Biol. 329 2003 45-57
94. S.E. Lipshultz K.A. Easley E.J. Orav S. Kaplan T.J. Starc J.T. Bricker W.W. Lai D.S. Moodie G. Sopko K. McIntosh S.D. Colan Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group N. Engl. J. Med. 343 2000 759-766
95. J.T. Lonergan C. Behling H. Pfander T.I. Hassanein W.C. Mathews Hyperlactatemis and hepatic abnormalities in ten HIV-infected patients taking multiples nucleoside analogs Clin. Infect. Dis. 29 1999 1022
96. J.T. Lonergan C. Behling H. Pfander T.I. Hassanein W.C. Mathews Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens Clin. Infect. Dis. 31 2000 162-166
97. J.T. Lonergan G. McComsey R.L. Fisher P. Shalit T.M.J. File D.J. Ward V.C. Williams L. Lindsey J.E. Hernandez E.T.S. Team Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir to zidovudine J. Acquir. Immune Defic. Syndr. 2004 in press
98. M.R. Loutfy N.L. Sheehan J.E. Goodhew S.L. Walmsley Inclusion body myositis: Another possible manifestation of antiretroviral-associated mitochondrial toxicity Aids 17 2003 1266-1267
99. B.B. Lowell B.M. Spiegelman Towards a molecular understanding of adaptive thermogenesis Nature 404 2000 652-660
100. R. Luzzati P. Del Bravo G. Di Perri A. Luzzani E. Concia Riboflavine and severe lactic acidosis Lancet 353 1999 901-902
101. N.E. Madias Lactic acidosis Kidney Int. 29 1986 752-774
102. S. Mallal D. Nolan C. Witt G. Masel A.M. Martin C. Moore D. Sayer A. Castley C. Mamotte D. Maxwell I. James F.T. Christiansen Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727-732
103. P.W. Mallon J. Miller D.A. Cooper A. Carr Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy Aids 17 2003 971-979
104. L. Mandelbrot N. Kermarrec A. Marcollet A. Lafanechere P. Longuet D. Chosidow M. Saada Case report: Nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy Aids 17 2003 272-273
105. G.J. Martin D.L. Blazes D.L. Mayers K.M. Spooner Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection Clin. Infect. Dis. 29 1999 459-460
106. C. Mayes C. Sweeney J.M. Savage C.M. Loughrey Pearson's syndrome: A multisystem disorder Acta Paediatr. 90 2001 235-237
107. G. McComsey Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy AIDS Rev. 4 2002 140-147
108. G.A. McComsey J.D. Morrow Lipid oxidative markers are significantly increased in lipoatrophy but not in sustained asymptomatic hyperlactatemia J. Acquir. Immune Defic. Syndr. 34 2003 45-49
109. G. McComsey D.M. Paulsen J.T. Lonergan D.F. Milano V.C. Williams G.E. Pakes J.E. Hernandez L.L. Ross Improvements in body fat, mitochondrial DNA (mtDNA) levels, and adipocyte apoptosis 48 weeks after replacing stavudine (d4T) with abacavir (ABC) or zidovudine (AZT) appear independent of cellular cytokine mRNA levels 41st IDSA, San Diego, Abstract 110 2003
110. K.D. Miller M. Cameron L.V. Wood M.C. Dalakas J.A. Kovacs Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases Ann. Intern. Med. 133 2000 192-196
111. M.H. Mokrzycki C. Harris H. May J. Laut J. Palmisano Lactic acidosis associated with stavudine administration: A report of five cases Clin. Infect. Dis. 30 2000 198-200
112. T.J. Montine J.M. Powers F.S. Vogel R.A. Radtke Alpers' syndrome presenting with seizures and multiple stroke-like episodes in a 17-year-old male Clin. Neuropathol. 14 1995 322-326
113. R.D. Moore W.M. Wong J.C. Keruly J.C. McArthur Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea Aids 14 2000 273-278
114. R.D. Moore J.C. Keruly R.E. Chaisson Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs Aids 15 2001 617-620
115. G. Moyle Hyperlactatemia and lactic acidosis during antiretroviral therapy: Causes, management, and possible aetiologies AIDS Rev. 3 2001 150-156
116. G.J. Moyle D. Datta S. Mandalia J. Morlese D. Asboe B.G. Gazzard Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors Aids 16 2002 1341-1349
117. A. Mukhopadhyay B. Wei S.J. Zullo L.V. Wood H. Weiner In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: A possible contribution to lipodystrophy syndrome Mitochondrion 1 2002 511-518
118. K. Muthumani D.S. Hwang B.M. Desai D. Zhang N. Dayes D.R. Green D.B. Weiner HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells J. Biol. Chem. 277 2002 37820-37831
119. K. Muthumani A.Y. Choo D.S. Hwang M.A. Chattergoon N.N. Dayes D. Zhang M.D. Lee U. Duvvuri D.B. Weiner Mechanism of HIV-1 viral protein R-induced apoptosis Biochem. Biophys. Res. Commun. 304 2003 583-592
120. D.C. Mynarcik T. Combs M.A. McNurlan P.E. Scherer E. Komaroff M.C. Gelato Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution J. Acquir. Immune Defic. Syndr. 31 2002 514-520
121. R.K. Naviaux W.L. Nyhan B.A. Barshop J. Poulton D. Markusic N.C. Karpinski R.H. Haas Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome Ann. Neurol. 45 1999 54-58
122. Z. Nie B.N. Phenix J.J. Lum A. Alam D.H. Lynch B. Beckett P.H. Krammer R.P. Sekaly A.D. Badley HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation Cell Death Differ. 9 2002 1172-1184
123. D. Nolan M. John S. Mallal Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis Antivir. Ther. 6 2001 145-160
124. A.E. Ogedegbe D.L. Thomas A.M. Diehl Hyperlactataemia syndromes associated with HIV therapy Lancet Infect. Dis. 3 2003 329-337
125. A. Oldfors A.R. Moslemi I.M. Fyhr E. Holme N.G. Larsson C. Lindberg Mitochondrial DNA deletions in muscle fibers in inclusion body myositis J. Neuropathol. Exp. Neurol. 54 1995 581-587
126. C.S. Pace A.M. Martin E.L. Hammond C.D. Mamotte D.A. Nolan S.A. Mallal Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients Antivir. Ther. 8 2003 323-331
127. H.A. Pearson J.S. Lobel S.A. Kocoshis J.L. Naiman J. Windmiller A.T. Lammi R. Hoffman J.C. Marsh A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction J. Pediatr. 95 1979 976-984
128. B.N. Phenix J.J. Lum Z. Nie J. Sanchez-Dardon A.D. Badley Antiapoptotic mechanism of HIV protease inhibitors: Preventing mitochondrial transmembrane potential loss Blood 98 2001 1078-1085
129. A.A. Pilon J.J. Lum J. Sanchez-Dardon B.N. Phenix R. Douglas A.D. Badley Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor Antimicrob. Agents Chemother. 46 2002 2687-2691
130. J. Poulton S. O'Rahilly K.J. Morten A. Clark Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome Diabetologia 38 1995 868-871
131. P. Puigserver Z. Wu C.W. Park R. Graves M. Wright B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829-839
132. S.M. Raidel C. Haase N.R. Jansen R.B. Russ R.L. Sutliff L.W. Velsor B.J. Day B.D. Hoit A.M. Samarel W. Lewis Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1672-H1678
133. D.D. Richman M.A. Fischl M.H. Grieco M.S. Gottlieb P.A. Volberding O.L. Laskin J.M. Leedom J.E. Groopman D. Mildvan M.S. Hirsch The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial N. Engl. J. Med. 317 1987 192-197
134. T. Roumier M. Castedo J.L. Perfettini K. Andreau D. Metivier N. Zamzami G. Kroemer Mitochondrion-dependent caspase activation by the HIV-1 envelope Biochem. Pharmacol. 66 2003 1321-1329
135. D. Salmon-Ceron L. Chauvelot-Moachon S. Abad B. Silbermann P. Sogni Mitochondrial toxic effects and ribavirin Lancet 357 2001 1803-1804
136. L. Sarner A. Fakoya Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication Sex. Transm. Infect. 78 2002 58-59
137. T. Schleiffer L.M. t Hart C. Schurfeld K. Kraatz J.F. Riemann Maternally inherited diabetes and deafness (MIDD): Unusual occult exocrine pancreatic manifestation in an affected German family Exp. Clin. Endocrinol. Diabetes 108 2000 81-85
138. A.J. Shaer A. Rastegar Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome. A case report and review of the literature Am. J. Nephrol. 20 2000 332-338
139. C.M. Shikuma N. Hu C. Milne F. Yost C. Waslien S. Shimizu B. Shiramizu Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy Aids 15 2001 1801-1809
140. B. Shiramizu K.M. Shikuma L. Kamemoto M. Gerschenson G. Erdem M. Pinti A. Cossarizza C. Shikuma Brief report: Placenta and cord blood mitochondrial dna toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy J. Acquir. Immune Defic. Syndr. 32 2003 370-374
141. D.M. Simpson M. Tagliati Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 1995 153-161
142. D.E. Smith A. Carr M. Law A. Martin J. Hudson J. Hoy D.A. Cooper Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: The PIILR extension study Aids 16 2002 2489-2491
143. R. Steet M. Alizadeh P. Melancon R.D. Kuchta 3′-Azidothymidine significantly alters glycosphingolipid synthesis in melanoma cells and decreases the shedding of gangliosides Glycoconj. J. 16 1999 237-245
144. R.A. Subbramanian E.A. Cohen Molecular biology of the human immunodeficiency virus accessory proteins J. Virol. 68 1994 6831-6835
145. E. Szabados G.M. Fischer K. Toth B. Csete B. Nemeti K. Trombitas T. Habon D. Endrei B. Sumegi Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat Free Radic. Biol. Med. 26 1999 309-317
146. J. Tanuma A. Ishizaki H. Gatanaga Y. Kikuchi S. Kimura M. Hiroe S. Oka Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen Clin. Infect. Dis. 37 2003 e109-e111
147. M. Toyono K. Nakano M. Kiuchi K. Imai H. Suzuki K. Shishikura M. Osawa K. Shiratori Y. Goto I. Nonaka H. Sugie A case of MERRF associated with chronic pancreatitis Neuromuscul. Disord. 11 2001 300-304
148. D. Trono HIV accessory proteins: Leading roles for the supporting cast Cell 82 1995 189-192
149. J. Turchan C.B. Pocernich C. Gairola A. Chauhan G. Schifitto D.A. Butterfield S. Buch O. Narayan A. Sinai J. Geiger J.R. Berger H. Elford A. Nath Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants Neurology 60 2003 307-314
150. D. Valenti A. Atlante M. Barile S. Passarella Inhibition of phosphate transport in rat heart mitochondria by 3′-azido-3′-deoxythymidine due to stimulation of superoxide anion mitochondrial production Biochem. Pharmacol. 64 2002 201-206
151. C. Vigouroux M. Maachi T.H. Nguyen C. Coussieu S. Gharakhanian T. Funahashi Y. Matsuzawa I. Shimomura W. Rozenbaum J. Capeau J.P. Bastard Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy Aids 17 2003 1503-1511
152. S.M. Vrouenraets M. Treskes R.M. Regez N. Troost Y.M. Smulders H.M. Weigel P.H. Frissen K. Brinkman Hyperlactataemia in HIV-infected patients: The role of NRTI-treatment Antivir. Ther. 7 2002 239-244
153. U.A. Walker N. Venhoff Multiple mitochondrial DNA deletions and lactic acidosis in an HIV-infected patient under antiretroviral therapy Aids 15 2001 1449-1450
154. U.A. Walker B. Setzer N. Venhoff Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors Aids 16 2002 2165-2173
155. U.A. Walker J. Bauerle M. Laguno J. Murillas S. Mauss G. Schmutz B. Setzer R. Miquel J.M. Gatell J. Mallolas Antiretroviral therapy with didanosine, stavudine, and zalcitabine is associated with depletion of mtDNA in the liver Antivir. Ther. 8 2003 L15-L16
156. D. Wolf V. Witte B. Laffert K. Blume E. Stromer S. Trapp P. d'Aloja A. Schurmann A.S. Baur HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals Nat. Med. 7 2001 1217-1224
157. Z. Wu P. Puigserver U. Andersson C. Zhang G. Adelmant V. Mootha A. Troy S. Cinti B. Lowell R.C. Scarpulla B.M. Spiegelman Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98 1999 115-124
158. J.P. Yan D.D. Ilsley C. Frohlick R. Steet E.T. Hall R.D. Kuchta P. Melancon 3′-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations J. Biol. Chem. 270 1995 22836-22841